This article is more than 5 years old. Information may no longer be current.
University of Chicago Medicine receives $6 million for colorectal cancer prevention
Click Here to Manage Email Alerts
The University of Chicago Medicine has been awarded $6 million over 5 years to test novel ways to improve colorectal cancer screening and follow-up among individuals who have not previously been screened, according to a press release.
The University of Chicago Medicine’s Center for Asian Health Equity will also join the National Cancer Institute’s Beau Biden Cancer Moonshot Initiative to accelerate the pace of progress in the fight against cancer, according to the release.
The university was one of three grantees nationwide that joins the Accelerating Colorectal Cancer Screening and Follow-up through Implementation Science Program.
The Program, according to the release, provides an evidence base for multilevel interventions that are aimed to increase colorectal cancer screening rates, follow-up and referral-to-care.
As a result of the award, the Center for Asian Health Equity will look to target underrepresented populations across Illinois.
“We are thrilled to have this opportunity to study the implementation of evidence-based interventions to increase colorectal cancer screening among vulnerable populations,” Karen E. Kim, MD, MS, associate director of the University of Chicago Comprehensive Cancer Center and director of the University of Chicago Medicine Comprehensive Cancer Center Office of Community Engagement and Cancer Disparities, said in the release. “ACCSIS-Chicago has the potential to transform our understanding of the health system and community factors that enhance or impede colorectal screening and follow up.”